This compound is a nucleoside phosphoramidite building block intermediate used in pharmaceutical manufacturing. It features a protected thymidine analog with dimethoxytrityl and benzoyl groups, and is designed for oligonucleotide synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 182496-01-1
N-Benzoyl-2'-O-(2-methoxyethyl)-5-methylcytidine
pharmaceutical intermediate
2,8-Dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-b]pyridazine
pharmaceutical intermediate
(S)-GNA-G(iBu) phosphoramidite
pharmaceutical intermediate
4-chloro-3-iodopyridine-2-carbonitrile
pharmaceutical intermediate
4-Iodobenzyl alcohol
pharmaceutical intermediate
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxy-5-methylcytidine
pharmaceutical intermediate
N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-O-((2-cyanoethoxy)(diisopropylamino)phosphino)-2'-O-(2-methoxyethyl)-5-methylcytidine
pharmaceutical intermediate
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-cytidine 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
pharmaceutical intermediate
N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-(2-methoxyethoxy)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
BYSCLUAIKFEFAH-LZURGKRNSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3[C@@H]([C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OCCOC